REDCARE PHARMACY NV (RDC.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:RDC - NL0012044747 - Common Stock
64.75 EUR
-0.25 (-0.38%)
We assign a fundamental rating of 3 out of 10 to RDC. RDC was compared to 26 industry peers in the Consumer Staples Distribution & Retail industry. RDC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, RDC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
RDC had negative earnings in the past year.
In the past year RDC had a positive cash flow from operations.
RDC had negative earnings in each of the past 5 years.
RDC had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of RDC (-2.88%) is worse than 76.92% of its industry peers.
Looking at the Return On Equity, with a value of -7.01%, RDC is doing worse than 76.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| ROIC | N/A |
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RDC has a Gross Margin of 22.88%. This is comparable to the rest of the industry: RDC outperforms 46.15% of its industry peers.
In the last couple of years the Gross Margin of RDC has grown nicely.
RDC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.88% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
2. Health
2.1 Basic Checks
RDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
RDC has less shares outstanding than it did 1 year ago.
RDC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RDC is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.30 indicates that RDC is not in any danger for bankruptcy at the moment.
RDC has a better Altman-Z score (3.30) than 65.38% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that RDC is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.62, RDC is doing good in the industry, outperforming 69.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.3 |
ROIC/WACCN/A
WACC6.68%
2.3 Liquidity
RDC has a Current Ratio of 1.68. This is a normal value and indicates that RDC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of RDC (1.68) is better than 92.31% of its industry peers.
A Quick Ratio of 1.23 indicates that RDC should not have too much problems paying its short term obligations.
RDC has a better Quick ratio (1.23) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.23 |
3. Growth
3.1 Past
The earnings per share for RDC have decreased strongly by -39.61% in the last year.
RDC shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.68%.
RDC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.59% yearly.
EPS 1Y (TTM)-39.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.86%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%25.18%
3.2 Future
RDC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.33% yearly.
RDC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.74% yearly.
EPS Next Y52.26%
EPS Next 2Y48.99%
EPS Next 3Y47.28%
EPS Next 5Y52.33%
Revenue Next Year25.07%
Revenue Next 2Y22.35%
Revenue Next 3Y20.54%
Revenue Next 5Y18.74%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
RDC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
RDC is valuated quite expensively with a Price/Forward Earnings ratio of 152.92.
RDC's Price/Forward Earnings ratio is rather expensive when compared to the industry. RDC is more expensive than 84.62% of the companies in the same industry.
RDC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.03.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 152.92 |
4.2 Price Multiples
80.77% of the companies in the same industry are cheaper than RDC, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 36.42 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RDC does not grow enough to justify the current Price/Earnings ratio.
RDC's earnings are expected to grow with 47.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.99%
EPS Next 3Y47.28%
5. Dividend
5.1 Amount
No dividends for RDC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:RDC (12/23/2025, 7:00:00 PM)
64.75
-0.25 (-0.38%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners51.41%
Inst Owner ChangeN/A
Ins Owners7.32%
Ins Owner ChangeN/A
Market Cap1.33B
Revenue(TTM)2.82B
Net Income(TTM)-35.19M
Analysts80
Price Target145.68 (124.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)150.51%
Min EPS beat(2)-12.8%
Max EPS beat(2)313.82%
EPS beat(4)2
Avg EPS beat(4)71.29%
Min EPS beat(4)-42.68%
Max EPS beat(4)313.82%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)-1.13%
Revenue beat(4)0
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-2.24%
Max Revenue beat(4)-0.77%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.41%
PT rev (3m)-7.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)39.28%
EPS NY rev (1m)4.18%
EPS NY rev (3m)8.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.65%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 152.92 | ||
| P/S | 0.47 | ||
| P/FCF | N/A | ||
| P/OCF | 40.61 | ||
| P/B | 2.65 | ||
| P/tB | 13.38 | ||
| EV/EBITDA | 36.42 |
EPS(TTM)-1.75
EYN/A
EPS(NY)0.42
Fwd EY0.65%
FCF(TTM)-2.99
FCFYN/A
OCF(TTM)1.59
OCFY2.46%
SpS137.07
BVpS24.41
TBVpS4.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.88% | ||
| FCFM | N/A |
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
F-Score3
Asset Turnover2.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.5 | ||
| Cap/Depr | 136.74% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 90.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | 3.3 |
F-Score3
WACC6.68%
ROIC/WACCN/A
Cap/Depr(3y)87.99%
Cap/Depr(5y)151.24%
Cap/Sales(3y)2.78%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.86%
EPS Next Y52.26%
EPS Next 2Y48.99%
EPS Next 3Y47.28%
EPS Next 5Y52.33%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%25.18%
Revenue Next Year25.07%
Revenue Next 2Y22.35%
Revenue Next 3Y20.54%
Revenue Next 5Y18.74%
EBIT growth 1Y-72.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year303.46%
EBIT Next 3Y94.63%
EBIT Next 5Y68.49%
FCF growth 1Y-2656.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.32%
OCF growth 3Y23.87%
OCF growth 5YN/A
REDCARE PHARMACY NV / RDC.DE FAQ
Can you provide the ChartMill fundamental rating for REDCARE PHARMACY NV?
ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE.
What is the valuation status of REDCARE PHARMACY NV (RDC.DE) stock?
ChartMill assigns a valuation rating of 1 / 10 to REDCARE PHARMACY NV (RDC.DE). This can be considered as Overvalued.
Can you provide the profitability details for REDCARE PHARMACY NV?
REDCARE PHARMACY NV (RDC.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for RDC stock?
The Earnings per Share (EPS) of REDCARE PHARMACY NV (RDC.DE) is expected to grow by 52.26% in the next year.